EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT

Ettore di Gaeta, Michela Olivieri, Annarita Savi, Patrizia Magnani, Carla Canevari, Simone Gusmini, Diego Palumbo, Giorgia Guazzarotti, Luigi Augello, Francesca Calabrese, Stephanie Steidler, Federica Cipriani und 5 weitere

La radiologia medica · 2024

DOI: 10.1007/s11547-024-01946-0 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift La radiologia medica, 2024. Verfasst von Ettore di Gaeta und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, IRCCS Ospedale San Raffaele, Milan, Italy. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Cone-Beam Computed Tomography, Embolization, Therapeutic, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Personalized treatment schemes are being systematically applied to ensure best treatment outcome in oncologic patients. This is true also for personalized dosimetry in transarterial radioembolization (TARE) in hepatocellular carcinoma (HCC) patients. Precise and detailed volumetric and functional data derived from radiological and nuclear imaging methods are essential for personalized dosimetry. We sought to evaluate accuracy of dual-phase cone-beam CT (CBCT) in comparison to pre-treatment contrast-enhanced CT (CECT), and 99m Tc-macroaggregated albumin-SPECT/CT ([ 99m Tc]MAA SPECT/CT) to predict and assess the efficacy of TARE based on post-treatment 90 Y PET/CT. Material and methods Thirty consecutive patients with HCC treated with TARE were included. Intraprocedural dual-phase CBCT acquisition protocol was developed to distinguish tumor volume in the early arterial phase and perfused volume of non-affected liver in the late arterial phase. Volumetric data obtained from pre-treatment CECT, dual-phase CBCT and [ 99 m Tc]MAA SPECT/CT were compared to post-treatment 90 Y PET/CT considered the standard reference. Treatment simulations for final calculated dose from the different imaging derived volumes were then compared to post-treatment 90 Y PET/CT.

Results

CBCT resulted as the most accurate method in predicting tumor- (R 2 0.89) and perfused volumes (R 2 0.84). Dosimetry prediction planning performed on derived volumes from the different methods did not show significant difference, yet highest concordance with 90 Y PET/CT data was observed with dual-phase CBCT.

Conclusion

Our study shows that dual-phase CBCT acquisition is a novel alternative method for correctly and safely administering more accurate and defined doses during TARE. clinicaltrials .gov ID: NCT03981497.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularCone-Beam Computed TomographyEmbolization, TherapeuticLiver NeoplasmsPositron Emission Tomography Computed TomographySingle Photon Emission Computed Tomography Computed TomographyYttrium RadioisotopesAgedFemaleHumansMaleMiddle AgedContrast MediaRadiometryRadiopharmaceuticalsTechnetium Tc 99m Aggregated Albumin

Stichwörter der Autor:innen

Cone-beam computed tomography (CBCT)Hepatocellular carcinoma (HCC)Personalized dosimetryTransarterial embolization (TARE)

Substanzen

Contrast MediaRadiopharmaceuticalsTechnetium Tc 99m Aggregated AlbuminYttrium RadioisotopesYttrium-90

Autor:innen und Institutionen

  • Department of Radiology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Department of Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy.
  • School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
  • Department of Hepatobiliary Surgery, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Department of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Department of Radiology, IRCCS Ospedale San Raffaele, Milan, Italy. decobelli.francesco@hsr.it.

Zitieren

APA

di Gaeta, E., Olivieri, M., Savi, A., Magnani, P., Canevari, C., Gusmini, S., Palumbo, D., Guazzarotti, G., Augello, L., Calabrese, F., Steidler, S., Cipriani, F., Rimini, M., Casadei-Gardini, A., Aldrighetti, L., Chiti, A., & De Cobelli, F. (2024). Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT. La radiologia medica. https://doi.org/10.1007/s11547-024-01946-0

Vancouver

di Gaeta E, Olivieri M, Savi A, Magnani P, Canevari C, Gusmini S, et al. Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT. La radiologia medica. 2024. doi:10.1007/s11547-024-01946-0

BibTeX
@article{diGaeta2024,
  author = {di Gaeta, Ettore and Olivieri, Michela and Savi, Annarita and Magnani, Patrizia and Canevari, Carla and Gusmini, Simone and Palumbo, Diego and Guazzarotti, Giorgia and Augello, Luigi and Calabrese, Francesca and Steidler, Stephanie and Cipriani, Federica and Rimini, Margherita and Casadei-Gardini, Andrea and Aldrighetti, Luca and Chiti, Arturo and De Cobelli, Francesco},
  title = {Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT},
  journal = {La radiologia medica},
  year = {2024},
  doi = {10.1007/s11547-024-01946-0}
}
Kostenlos starten →